What advances have been made in immune-therapy for renal cell carcinoma?

Future Oncol. 2017 Apr;13(8):665-668. doi: 10.2217/fon-2017-0026. Epub 2017 Feb 10.

Authors

Elena Verzoni¹, Paolo Grassi¹, Raffaele Ratta¹

Affiliation

¹ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.

PMID: 28183189
DOI: 10.2217/fon-2017-0026

No abstract available

Keywords: immune-checkpoint inhibitors; immunotherapy; renal cell carcinoma.

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use*
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / immunology
Carcinoma, Renal Cell / mortality
Carcinoma, Renal Cell / pathology
Clinical Trials as Topic
Humans
Immunotherapy*
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / immunology
Kidney Neoplasms / mortality
Kidney Neoplasms / pathology
Molecular Targeted Therapy*
Treatment Outcome

Substances

Antineoplastic Agents, Immunological